Paul Armistead is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 177 publications with 2,582 citations (h-index 27); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Dr
Chapel Hill, NC 275990001
Telephone
919-966-4131Registry record last updated 17 Mar 2009.
Clinical trials
- Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- SOBI, INCProgram year20251 payment
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor19.7%Valacyclovir100%Part D≥15 patientsMacrolide Antimicrobial6.3%Azithromycin100%Part D<11 patientsCancer & immunology
23.7%Kinase inhibitor13.7%Jakafi100%Part D<11 patientsSelective immunosuppressants10%Rezurock100%Part D<11 patientsCardiovascular
17%Statin7.3%Rosuvastatin Calcium100%Part D<11 patientsLoop diuretic5%Furosemide100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2012–2020 per NIH RePORTER. The latest:
- Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
Univ of North Carolina Chapel Hill
FY2020$450,736R01CA201225 - Microfabricated instrumentation to measure sphingolipid signaling in human acute myeloid leukemia
Univ of North Carolina Chapel Hill
FY2019$586,757R01CA233811 - Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
Univ of North Carolina Chapel Hill
FY2019$456,823R01CA201225
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”